Annual Current Liabilities
$846.60 M
+$93.80 M+12.46%
31 December 2023
Summary:
Amneal Pharmaceuticals annual total current liabilities is currently $846.60 million, with the most recent change of +$93.80 million (+12.46%) on 31 December 2023. During the last 3 years, it has risen by +$169.69 million (+25.07%). AMRX annual current liabilities is now at all-time high.AMRX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$1.10 B
-$19.14 M-1.72%
30 September 2024
Summary:
Amneal Pharmaceuticals quarterly total current liabilities is currently $1.10 billion, with the most recent change of -$19.14 million (-1.72%) on 30 September 2024. Over the past year, it has increased by +$334.61 million (+43.99%). AMRX quarterly current liabilities is now -1.72% below its all-time high of $1.11 billion, reached on 30 June 2024.AMRX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMRX Current Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +12.5% | +44.0% |
3 y3 years | +25.1% | +64.1% |
5 y5 years | +52.9% | +104.8% |
AMRX Current Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +25.1% | -1.7% | +81.9% |
5 y | 5 years | at high | +53.8% | -1.7% | +104.8% |
alltime | all time | at high | +185.2% | -1.7% | +268.9% |
Amneal Pharmaceuticals Current Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $1.10 B(-1.7%) |
June 2024 | - | $1.11 B(+33.6%) |
Mar 2024 | - | $834.39 M(-1.4%) |
Dec 2023 | $846.60 M(+12.5%) | $846.60 M(+11.3%) |
Sept 2023 | - | $760.60 M(-2.2%) |
June 2023 | - | $777.35 M(+10.5%) |
Mar 2023 | - | $703.71 M(-6.5%) |
Dec 2022 | $752.80 M(+11.2%) | $752.80 M(-8.0%) |
Sept 2022 | - | $818.00 M(-17.6%) |
June 2022 | - | $993.06 M(+64.9%) |
Mar 2022 | - | $602.04 M(-11.1%) |
Dec 2021 | $677.24 M | $677.24 M(+1.5%) |
Sept 2021 | - | $667.34 M(-0.8%) |
Date | Annual | Quarterly |
---|---|---|
June 2021 | - | $672.86 M(+5.7%) |
Mar 2021 | - | $636.78 M(-5.9%) |
Dec 2020 | $676.90 M(+23.0%) | $676.90 M(+1.3%) |
Sept 2020 | - | $667.89 M(+2.0%) |
June 2020 | - | $655.02 M(-32.1%) |
Mar 2020 | - | $965.07 M(+75.3%) |
Dec 2019 | $550.41 M(-0.6%) | $550.41 M(+2.9%) |
Sept 2019 | - | $534.91 M(-2.1%) |
June 2019 | - | $546.16 M(-8.9%) |
Mar 2019 | - | $599.53 M(+8.2%) |
Dec 2018 | $553.85 M(+86.6%) | $553.85 M(-26.1%) |
Sept 2018 | - | $749.27 M(+11.9%) |
June 2018 | - | $669.74 M(+125.6%) |
Dec 2017 | $296.88 M | $296.88 M |
FAQ
- What is Amneal Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals annual current liabilities year-on-year change?
- What is Amneal Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals quarterly current liabilities year-on-year change?
What is Amneal Pharmaceuticals annual total current liabilities?
The current annual current liabilities of AMRX is $846.60 M
What is the all time high annual current liabilities for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high annual total current liabilities is $846.60 M
What is Amneal Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, AMRX annual total current liabilities has changed by +$93.80 M (+12.46%)
What is Amneal Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of AMRX is $1.10 B
What is the all time high quarterly current liabilities for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high quarterly total current liabilities is $1.11 B
What is Amneal Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, AMRX quarterly total current liabilities has changed by +$334.61 M (+43.99%)